ORBIMED ADVISORS LLC 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-06 4:43 pm Sale | 2023-12-04 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 3,567,159 4.900% | -611,429 (-14.63%) | Filing |
| 2023-05-17 4:46 pm Sale | 2023-05-15 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 4,178,588 6.700% | -806,412 (-16.18%) | Filing |
| 2023-01-05 4:40 pm Sale | 2023-01-03 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 4,985,000 8.000% | -614,842 (-10.98%) | Filing |
| 2022-09-14 4:34 pm Sale | 2022-09-12 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 5,599,842 9.300% | -586,465 (-9.48%) | Filing |
| 2021-03-03 6:50 pm Sale | 2021-03-01 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 6,186,307 12.600% | -1,220,000 (-16.47%) | Filing |
| 2020-10-13 9:14 pm Unchanged | 2020-10-13 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 7,406,307 15.500% | 0 (Unchanged) | Filing |